Autoantibodies that deplete or inhibit activity of target coagulation factors (most commonly factor VIII) leading to development of bleeding complications. Learn more here.
Oct
11
2021
Oct
11
2021
Autoantibodies that deplete or inhibit activity of target coagulation factors (most commonly factor VIII) leading to development of bleeding complications. Learn more here.